These newfound insights into the intricate interactions between the immune system and cancer cells has opened new avenues of treatment, such as checkpoint blockade via targeting of CTLA-4 and PD-1/PDL1, with the goal of recruiting and promoting immune cells to eliminate tumor cells. Here, CD274 is linked to neoplasm.